BCG REVAX

BCG REVAX

A Randomized, Placebo Controlled, Observer-Blind, Phase IIb Study to Evaluate the Efficacy, Safety, and Immunogenicity of BCG revaccination in Healthy Adolescents for the Prevention of Sustained Infection with Mycobacterium tuberculosis.
Latest Update: 15 February 2021

For more about BCG REVAX please email rhicomms@wrhi.ac.za